Literature DB >> 19054196

The influence of educational level on polypharmacy and inappropriate drug use: a register-based study of more than 600,000 older people.

Syed Imran Haider1, Kristina Johnell, Gunilla Ringbäck Weitoft, Mats Thorslund, Johan Fastbom.   

Abstract

OBJECTIVES: To investigate whether low educational attainment is associated with polypharmacy and potential inappropriate drug use (IDU) in older people.
DESIGN: Cross-sectional register-based study.
SETTING: Sweden. PARTICIPANTS: Older people aged 75 to 89 who, filled at least one drug prescription between August and October 2005 and, consequently, were listed in the Swedish Prescribed Drug Register (SPDR) (N=626,258). Data were obtained from the SPDR, the inpatient register, and the education register. MEASUREMENTS: The main outcome measures were polypharmacy (concurrent use of > or =5 drugs), excessive polypharmacy (concurrent use of > or =10 drugs), and potential IDU. Four quality indicators developed by the Swedish National Board of Health and Welfare were used for the assessment of potential IDU: concurrent use of three or more psychotropic drugs, prescription of long-acting benzodiazepines, prescription of anticholinergics, and at least one clinically relevant potential drug-drug interaction (DDI). Comorbidity was measured using the Charlson Comorbidity Index.
RESULTS: Subjects with low education had a higher probability of polypharmacy (odds ratio (OR)=1.11, 95% confidence interval (CI)=1.10-1.12), excessive polypharmacy (OR=1.15, 95% CI=1.13-1.17), and potential IDU (OR=1.09, 95% CI=1.07-1.17), after adjustment for age, sex, comorbidity, and type of residential area (urban or rural). Decreasing educational attainment was associated with a higher probability of using three or more psychotropic drugs and potential DDIs, whereas the opposite association was observed for anticholinergic drugs. Long-acting benzodiazepines showed no association. Elderly women with low education were slightly more likely to have polypharmacy, excessive polypharmacy, and potential IDU than men with low education. Overall, the ORs were modest and statistically significant because of the large sample size.
CONCLUSION: Low educational attainment was associated with a greater likelihood of poypharmacy, excessive polypharmacy, and potential IDU in elderly Swedish persons, even after controlling for age, sex, place of residence, and comorbidity. Women with low education had slightly higher likelihood of receiving polypharmacy and potential IDU than men with low education. The recently established SPDR may be useful for continuous monitoring and for designing interventions to improve drug quality in low-educated elderly people.

Entities:  

Mesh:

Year:  2008        PMID: 19054196     DOI: 10.1111/j.1532-5415.2008.02040.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  80 in total

1.  Pharmacological treatment of Alzheimer's disease: effect of race and demographic variables.

Authors:  Santiago Hernandez; McKee J McClendon; Xiao-Hua Andrew Zhou; Michael Sachs; Alan J Lerner
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

2.  Prescribed-drug utilization and polypharmacy in a general population in Greece: association with sociodemographic, health needs, health-services utilization, and lifestyle factors.

Authors:  E Pappa; N Kontodimopoulos; A A Papadopoulos; Y Tountas; D Niakas
Journal:  Eur J Clin Pharmacol       Date:  2010-11-11       Impact factor: 2.953

3.  Prevalence and Geographic Variations of Polypharmacy Among West Virginia Medicaid Beneficiaries.

Authors:  Xue Feng; Xi Tan; Brittany Riley; Tianyu Zheng; Thomas K Bias; James B Becker; Usha Sambamoorthi
Journal:  Ann Pharmacother       Date:  2017-06-21       Impact factor: 3.154

4.  Comparison of prescription drug use between community-dwelling and institutionalized elderly in Sweden.

Authors:  Kristina Johnell; Johan Fastbom
Journal:  Drugs Aging       Date:  2012-09       Impact factor: 3.923

5.  Effect of polypharmacy, potentially inappropriate medications and anticholinergic burden on clinical outcomes: a retrospective cohort study.

Authors:  Wan-Hsuan Lu; Yu-Wen Wen; Liang-Kung Chen; Fei-Yuan Hsiao
Journal:  CMAJ       Date:  2015-02-02       Impact factor: 8.262

6.  Excessive polypharmacy and survival in polypathological patients.

Authors:  Jesús Díez-Manglano; Mercedes Giménez-López; Vanesa Garcés-Horna; María Sevil-Puras; Elena Castellar-Otín; Paloma González-García; Isabel Fiteni-Mera; Teresa Morlanes-Navarro
Journal:  Eur J Clin Pharmacol       Date:  2015-04-26       Impact factor: 2.953

7.  Epidemiology of Polypharmacy and Potential Drug-Drug Interactions Among Pediatric Patients in ICUs of U.S. Children's Hospitals.

Authors:  Dingwei Dai; James A Feinstein; Wynne Morrison; Athena F Zuppa; Chris Feudtner
Journal:  Pediatr Crit Care Med       Date:  2016-05       Impact factor: 3.624

8.  Geographical differences in the prevalence of chronic polypharmacy in older people: eleven years of the EPIFARM-Elderly Project.

Authors:  Carlotta Franchi; Massimo Cartabia; Paolo Risso; Daniela Mari; Mauro Tettamanti; Alberto Parabiaghi; Luca Pasina; Codjo Djignefa Djade; Ida Fortino; Angela Bortolotti; Luca Merlino; Alessandro Nobili
Journal:  Eur J Clin Pharmacol       Date:  2013-03-28       Impact factor: 2.953

9.  Socioeconomic determinants of psychotropic drug utilisation among elderly: a national population-based cross-sectional study.

Authors:  Eva Lesén; Karolina Andersson; Max Petzold; Anders Carlsten
Journal:  BMC Public Health       Date:  2010-03-09       Impact factor: 3.295

10.  Dispensed drugs and multiple medications in the Swedish population: an individual-based register study.

Authors:  Bo Hovstadius; Bengt Astrand; Göran Petersson
Journal:  BMC Clin Pharmacol       Date:  2009-05-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.